RESUMO
INTRODUCCIÓN: La enfermedad pulmonar obstructiva crónica (EPOC) se asocia frecuentemente con la presencia de trastornos del ánimo, que pueden pasar desapercibidos. El objetivo de este estudio es determinar la prevalencia de ansiedad y depresión en pacientes con EPOC y analizar su relación con las puntuaciones en la escala HADS (Hospital Anxiety and Depression Scale). PACIENTES Y MÉTODOS: Estudio prospectivo, observacional, con un seguimiento a 3 meses, en el que se recogen diversas variables, incluyendo características clínicas, cuestionarios de calidad de vida y tratamientos realizados. RESULTADOS: Se incluyeron en el estudio 143 pacientes con EPOC (88,9% varones), con una edad media de 72,76 ± 9,72 años. El valor medio del FEV1 fue de 47,23 ± 19,44%. El 8,6% presentaba un diagnóstico previo de depresión y el 3,3% de ansiedad. La puntuación media en la escala HADS fue 6,96 ± 6,50 puntos (3,55 ± 3,54 en la subescala de depresión y 3,41 ± 3,76 en la de ansiedad). Obtuvimos un 5,6% de casos probables en la subescala de depresión y un 4,9% en la de ansiedad. El 14,3% de los pacientes con HADS ≥ 11 presentaban diagnóstico previo de ansiedad y el 12,5% de depresión. CONCLUSIONES: El 8,6% de nuestros pacientes presentaba un diagnóstico previo de depresión y el 3,3% de ansiedad. Así mismo, en la escala HADS obtuvimos un 5,6% de casos probables en la subescala de depresión y un 4,9% en la de ansiedad. Por otro lado, un porcentaje destacable de pacientes con EPOC y ansiedad o depresión tenían una puntuación elevada en la escala HADS
INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is frequently associated with the presence of mood disorders, which can go unnoticed. The objective of this study is to determine the prevalence of anxiety and depression in patients with COPD and to analyze its relationship with scores on the HADS scale (Hospital Anxiety and Depression Scale). PATIENTS AND METHODS: Prospective, observational study, with a 3-month follow-up, in which various variables are collected, including clinical characteristics, quality of life questionnaires and treatments performed. RESULTS: 143 patients with COPD (88.9% male) were included in the study, with a mean age of 72.76 ± 9.72 years. The mean FEV1 value was 47.23 ± 19.44%. 8.6% had a previous diagnosis of depression and 3.3% of anxiety. The mean score on the HADS scale was 6.96 ± 6.50 points (3.55 ± 3.54 in the depression subscale and 3.41 ± 3.76 in the anxiety subscale). We obtained 5.6% of probable cases in the depression subscale and 4.9% in the anxiety subscale. 14.3% of the patients with HADS> 11 had a previous diagnosis of anxiety and 12.5% of depression. CONCLUSIONS: 8.6% of our patients had a previous diagnosis of depression and 3.3% of anxiety. Likewise, in the HADS scale we obtained 5.6% of probable cases in the depression subscale and 4.9% in the anxiety subscale. On the other hand, a remarkable percentage of patients with COPD and anxiety or depression had a high score on the HADS scale
Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Doença Pulmonar Obstrutiva Crônica/psicologia , Doença Pulmonar Obstrutiva Crônica/epidemiologia , Exacerbação dos Sintomas , Ansiedade/epidemiologia , Depressão/epidemiologia , Estudos Prospectivos , Escalas de Graduação Psiquiátrica , Qualidade de Vida , Inquéritos e Questionários , Prevalência , Seguimentos , Espanha/epidemiologiaRESUMO
SETD1B is a component of a histone methyltransferase complex that specifically methylates Lys-4 of histone H3 (H3K4) and is responsible for the epigenetic control of chromatin structure and gene expression. De novo microdeletions encompassing this gene as well as de novo missense mutations were previously linked to syndromic intellectual disability (ID). Here, we identify a specific hypermethylation signature associated with loss of function mutations in the SETD1B gene which may be used as an epigenetic marker supporting the diagnosis of syndromic SETD1B-related diseases. We demonstrate the clinical utility of this unique epi-signature by reclassifying previously identified SETD1B VUS (variant of uncertain significance) in two patients.
Assuntos
Ansiedade/genética , Transtorno do Espectro Autista/genética , Metilação de DNA , Epilepsia/genética , Histona-Lisina N-Metiltransferase/genética , Deficiência Intelectual/genética , Mutação com Perda de Função , Adolescente , Adulto , Criança , Pré-Escolar , Ilhas de CpG , Epigênese Genética , Proteínas F-Box/genética , Feminino , Marcadores Genéticos , Humanos , Recém-Nascido , Histona Desmetilases com o Domínio Jumonji/genética , MasculinoRESUMO
El presente trabajo pretende socializar los principales resultados alcanzados en la aplicación de un plan de acciones comunitarias para contribuir a la atención de menores con Necesidades Educativas Especiales desde el trabajo intersectorial salud-educación en un Consejo Popular en el municipio Yaguajay, como parte de un proyecto institucional en función de la tesis de maestría en Gestión del Desarrollo Local. La metodología utilizada asume como método general el dialéctico materialista. Se emplearon métodos teóricos, empíricos y estadísticos matemáticos para el procesamiento de datos. Se revisaron los referentes teóricos que dieron sustento a esta investigación y permitieron la proyección de las acciones comunitarias intersectoriales, las mismas permiten el vínculo entre sectores como el MINED, MINSAP, INDER, FMC, CDR, Cultura, Órgano del Trabajo, Biblioteca pública, ANAP, Gobierno y PCC en la atención a menores con Necesidades Educativas Especiales en el Consejo Popular.[AU]
Assuntos
Humanos , Política Pública , Colaboração IntersetorialRESUMO
Microcephaly is a rare condition in which the occipitofrontal circumference in a child is more than two standard deviations below the mean of children of the same age and gender. It is mainly caused by genetic abnormalities that interfere with the growth of the cerebral cortex during early months of fetal development. We present a case of a 12â¯years old patient with microcephaly. To identify a possible genetic origin of the phenotype, we performed array CGH and exome sequencing in the patient. Exome sequencing revealed the presence of a de novo missense mutation in the TUBB5 gene (E401K). Mutations in the TUBB5 are mainly responsible for microcephaly but the clinical spectrum is wide, from patients with severe developmental delay, and the presence of different brain malformations, to patients with only slightly cognitive impairment and normal motor development. Our patient shows a milder phenotype than other patients carrying the same mutation. These differences in the clinical features suggest that other factors, presumably genetic or epigenetic, could be modulating clinical expressivity of TUBB5. It is therefore evident that more functional studies are needed to understand the pathology that underlies the clinical spectrum of tubulin associated disease states.
Assuntos
Deficiências do Desenvolvimento/genética , Microcefalia/genética , Malformações do Sistema Nervoso/genética , Tubulina (Proteína)/genética , Criança , Deficiências do Desenvolvimento/diagnóstico , Deficiências do Desenvolvimento/fisiopatologia , Exoma/genética , Feminino , Humanos , Masculino , Microcefalia/diagnóstico , Microcefalia/fisiopatologia , Mutação , Malformações do Sistema Nervoso/diagnóstico , Malformações do Sistema Nervoso/fisiopatologiaRESUMO
OBJECTIVE: To assess the added value of chromosomal microarray analysis (CMA) over conventional karyotyping to assess the genetic causes in stillbirth. METHODS: To identify relevant studies, published in English or Spanish and without publication time restrictions, we performed a systematic search of PubMed, SCOPUS and ISI Web of Science databases, The Cochrane Library and the PROSPERO register of systematic reviews, for case series of fetal loss ≥ 20 weeks of gestation, with normal or suspected normal karyotype, undergoing CMA and with at least five subjects analyzed. To investigate quality, two reviewers evaluated independently the risk of bias using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool. For the meta-analysis, the incremental yield of CMA over karyotyping was assessed by single-proportion analysis using a random-effects model (weighting by inverse variance). We assessed heterogeneity between studies and performed a sensitivity analysis and a subgroup analysis of structurally abnormal (malformed or growth-restricted) and normal fetuses. RESULTS: Included in the meta-analysis were seven studies involving 903 stillborn fetuses which had normal karyotype. The test success rate achieved by conventional cytogenetic analysis was 75%, while that for CMA was 90%. The incremental yield of CMA over conventional karyotyping based on the random-effects model was 4% (95% CI, 3-5%) for pathogenic copy-number variants (pCNVs) and 8% (95% CI, 4-17%) for variants of unknown significance. Subgroup analysis showed a 6% (95% CI, 4-10%) incremental yield of CMA for pCNVs in structurally abnormal fetuses and 3% (95% CI, 1-5%) incremental yield for those in structurally normal fetuses. The pCNV found most commonly was del22q11.21. CONCLUSIONS: CMA, incorporated into the stillbirth work-up, improves both the test success rate and the detection of genetic anomalies compared with conventional karyotyping. To achieve a genetic diagnosis in stillbirth is particularly relevant for the purpose of counseling regarding future pregnancies. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.
Valor añadido del análisis de microarrays cromosómicos sobre el cariotipado convencional en el estudio de éxitus fetal: revisión sistemática y metaanálisis OBJETIVO: Evaluar el valor añadido del análisis de microarrays cromosómicos (AMC) sobre el cariotipado convencional para evaluar las causas genéticas en el éxitus fetal. MÉTODOS: Para identificar estudios relevantes, publicados en inglés o español y sin restricciones de tiempo de la publicación, se realizó una búsqueda sistemática en las bases de datos PubMed, SCOPUS e ISI Web of Science, The Cochrane Library y el registro de revisiones sistemáticas PROSPERO, para series de casos de pérdida fetal ≥ 20 semanas de gestación, con cariotipo normal o presuntamente normal, sometidos a AMC y con al menos cinco sujetos analizados. Para investigar la calidad, dos revisores evaluaron de forma independiente el riesgo de sesgo mediante la herramienta Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2). Para el metaanálisis, se evaluó el rendimiento incremental del AMC sobre el cariotipado mediante un análisis de proporción única que empleó un modelo de efectos aleatorios (ponderación por varianza inversa). Se evaluó la heterogeneidad entre los estudios y se realizó un análisis de sensibilidad y un análisis de subgrupos de fetos estructuralmente anómalos (con malformación o con restricción del crecimiento) y normales. RESULTADOS: En el metaanálisis se incluyó siete estudios que comprendían 903 casos de éxitus fetal con cariotipo normal. La tasa de éxito de la prueba alcanzada mediante el análisis citogenético convencional fue del 75%, mientras que la del AMC fue del 90%. El rendimiento incremental del AMC sobre el cariotipado convencional en el modelo de efectos aleatorios fue del 4% (IC 95%, 3-5%) para las variantes patógenas del número de copias (VNCp) y del 8% (IC 95%, 4-17%) para las variantes de significancia desconocida. El análisis de subgrupos mostró un rendimiento incremental del AMC del 6% (IC 95%, 4-10%) para los fetos estructuralmente anormales y del 3% (IC 95%, 1-5%) para los fetos estructuralmente normales. La VNCp encontrada más comúnmente fue del22q11.21. CONCLUSIONES: El AMC, incorporado en el estudio del éxitus fetal, mejora tanto la tasa de éxito de las pruebas como la detección de anomalías genéticas en comparación con el cariotipado convencional. El diagnóstico genético en el éxitus fetal es especialmente relevante para el asesoramiento en futuros embarazos.
Assuntos
Doenças Fetais/diagnóstico , Cariotipagem/estatística & dados numéricos , Análise em Microsséries/estatística & dados numéricos , Natimorto/genética , Aberrações Cromossômicas/embriologia , Feminino , Doenças Fetais/genética , Humanos , Cariotipagem/métodos , Análise em Microsséries/métodos , GravidezRESUMO
FMR1 premutation carriers (55-200 CGGs) are at risk of developing Fragile X-associated primary ovarian insufficiency as well as Fragile X-associated tremor/ataxia syndrome. FMR1 premutation alleles are also associated with a variety of disorders, including psychiatric, developmental, and neurological problems. However, there is a major concern regarding clinical implications of smaller CGG expansions known as intermediate alleles (IA) or gray zone alleles (45-54 CGG). Although several studies have hypothesized that IA may be involved in the etiology of FMR1 premutation associated phenotypes, this association still remains unclear. The aim of this study was to provide new data on the clinical implications of IA. We reviewed a total of 17 011 individuals: 1142 with primary ovarian insufficiency, 478 with movement disorders, 14 006 with neurodevelopmental disorders and 1385 controls. Similar IA frequencies were detected in all the cases and controls (cases 1.20% vs controls 1.39%, P = .427). When comparing the allelic frequencies of IA ≥ 50CGGs, a greater, albeit not statistically significant, number of alleles were detected in all the cohorts of patients. Therefore, IA below 50 CGGs should not be considered as risk factors for FMR1 premutation-associated phenotypes, at least in our population. However, the clinical implication of IA ≥ 50CGGs remains to be further elucidated.
Assuntos
Alelos , Proteína do X Frágil da Deficiência Intelectual/genética , Predisposição Genética para Doença , Variação Genética , População Branca/genética , Adulto , Feminino , Frequência do Gene , Estudos de Associação Genética , Genótipo , Humanos , Masculino , Pessoa de Meia-Idade , Vigilância da População , Espanha , Adulto JovemRESUMO
Fragile X syndrome (FXS) is the most common cause of inherited intellectual disability and the leading form of the monogenic cause of autism. Fragile X mental retardation type 1 (FMR1) gene premutation is the first single-gene cause of primary ovarian failure (Fragile X-associated primary ovarian insufficiency [FXPOI]) and one of the most common causes of ataxia (fragile X-associated tremor/ataxia syndrome [FXTAS]), multiple additional phenotypes such as fibromyalgia, hypothyroidism, migraine headaches, sleep disturbances, sleep apnea, restless legs syndrome, central pain syndrome, neuropathy and neuropsychiatric alterations has been described. Clinical involvement in men and women carrying the FMR1 premutation currently constitutes a real health problem in the society that should be taken into account. It is important to highlight that while in FXS there is a loss-of-function of the FMR1 gene, in premutation associated disorders there is a gain of FMR1 mRNA function. To date, the tremendous progress achieved in the understanding of the pathophysiology of FXS, has led to the development of several targeted therapies aimed at preventing or improving the neurological manifestations of the disease. This review is an update of the diseases associated with the FMR1 gene.
Assuntos
Ataxia/genética , Proteína do X Frágil da Deficiência Intelectual/genética , Síndrome do Cromossomo X Frágil/genética , Insuficiência Ovariana Primária/genética , Tremor/genética , Ataxia/patologia , Transtorno Autístico/genética , Transtorno Autístico/patologia , Feminino , Síndrome do Cromossomo X Frágil/patologia , Heterozigoto , Humanos , Deficiência Intelectual/genética , Deficiência Intelectual/patologia , Masculino , Insuficiência Ovariana Primária/patologia , Tremor/patologiaRESUMO
Behavioral symptoms and traits have been proposed as early markers in neurodegenerative diseases. The aim of this study was to evaluate social anxiety and autism in FMR1 premutation carriers using the Social Phobia Inventory (SPIN) and the Autism-Spectrum Quotient (AQ) questionnaires. Fifty-nine premutation carriers were compared with 50 controls. The SPIN test showed statistically significant differences between female but not male carriers. The AQ questionnaire found statistically significant differences between premutation carriers and controls in the total AQ as well as in the social skills and attention switching subdomains. A gender effect was only observed for the social skills subdomain. Spearman's correlation analysis revealed a moderately positive correlation with the total AQ scores as well as the social skills and communication subdomains. Our results show that fragile X-associated tremor/ataxia syndrome (FXTAS) patients have higher AQ scores. Moreover, this is the first study to find statistically significant differences between FXTAS and no-FXTAS premutation carriers in the communication and the imagination subdomains, suggesting that FXTAS patients present a broader autistic phenotype than premutation carriers without FXTAS. Based on our results, a wide range of behavioral/psychiatric traits should be included within the broader phenotypic presentation of individuals with the FMR1 premutation.
Assuntos
Transtornos de Ansiedade/genética , Transtorno Autístico/genética , Proteína do X Frágil da Deficiência Intelectual/genética , Transtornos do Comportamento Social/genética , Expansão das Repetições de Trinucleotídeos/genética , Adulto , Idoso , Ataxia/genética , Feminino , Síndrome do Cromossomo X Frágil/genética , Heterozigoto , Humanos , Masculino , Pessoa de Meia-Idade , Fobia Social/genética , Fatores Sexuais , Inquéritos e Questionários , Tremor/genéticaRESUMO
Mitochondrial involvement plays an important role in neurodegenerative diseases. At least one-third of adult carriers of a FMR1 premutation (55-200 CGG repeats) are at risk of presenting an adult-onset neurodegenerative disorder known as fragile X-associated tremor/ataxia syndrome (FXTAS). In an attempt to provide new insights into the mechanisms involved in the pathogenesis of FXTAS, we characterized mitochondrial function and dynamics by the assessment of oxidative respiratory chain function, mitochondrial content, oxidative stress levels, and mitochondrial network complexity. Regarding mitochondrial function, we found that mitochondrial respiratory capacity is compromised in skin fibroblasts whereas in blood, no differences were observed between the FXTAS and control groups. Furthermore, fibroblasts from FXTAS patients presented altered mitochondrial architecture, with more circular and less interconnected mitochondria being observed. Mitochondrial function and dynamics deregulation and characteristic of neurological disorders are present in FXTAS patients. These features might be limiting temporal and spatial bioenergetics cells supply and thus contributing to disease pathogenesis.
Assuntos
Ataxia/metabolismo , Síndrome do Cromossomo X Frágil/metabolismo , Mitocôndrias/fisiologia , Tremor/metabolismo , Ataxia/patologia , Feminino , Fibroblastos/patologia , Fibroblastos/fisiologia , Síndrome do Cromossomo X Frágil/patologia , Humanos , Leucócitos Mononucleares/patologia , Leucócitos Mononucleares/fisiologia , Masculino , Mitocôndrias/patologia , Tremor/patologiaRESUMO
FMR1 premutation female carriers are at risk for Fragile X-associated primary ovarian insufficiency (FXPOI). Insights from knock-in mouse model have recently demonstrated that FXPOI is due to an increased rate of follicle depletion or an impaired development of the growing follicles. Molecular mechanisms responsible for this reduced viability are still unknown. In an attempt to provide new data on the mechanisms that lead to FXPOI, we report the first investigation involving transcription profiling of total blood from FMR1 premutation female carriers with and without FXPOI. A total of 16 unrelated female individuals (6 FMR1 premutated females with FXPOI; 6 FMR1 premutated females without FXPOI; and 4 no-FXPOI females) were studied by whole human genome oligonucleotide microarray (Agilent Technologies). Fold change analysis did not show any genes with significant differential gene expression. However, functional profiling by gene set analysis showed large number of statistically significant deregulated GO annotations as well as numerous KEGG pathways in FXPOI females. These results suggest that the impairment of fertility in these females might be due to a generalized deregulation of key signaling pathways involved in oocyte maturation. In particular, the vasoendotelial growth factor signaling, the inositol phosphate metabolism, the cell cycle, and the MAPK signaling pathways were found to be down-regulated in FXPOI females. Furthermore, a high statistical enrichment of biological processes involved in cell death and survival were found deregulated among FXPOI females. Our results provide new strategic approaches to further investigate the molecular mechanisms and potential therapeutic targets for FXPOI not focused in a single gene but rather in the set of genes involved in these pathways.
Assuntos
Proteína do X Frágil da Deficiência Intelectual/genética , Síndrome do Cromossomo X Frágil/genética , Regulação da Expressão Gênica no Desenvolvimento , Oócitos/metabolismo , Insuficiência Ovariana Primária/genética , Transdução de Sinais/genética , Adulto , Idoso , Feminino , Síndrome do Cromossomo X Frágil/patologia , Perfilação da Expressão Gênica/métodos , Ontologia Genética , Estudo de Associação Genômica Ampla/métodos , Heterozigoto , Humanos , Pessoa de Meia-Idade , Modelos Genéticos , Mutação , Análise de Sequência com Séries de Oligonucleotídeos , Oócitos/crescimento & desenvolvimento , Insuficiência Ovariana Primária/patologiaRESUMO
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder associated with FMR1 gene premutation alleles (55-200 CGG repeats). Fragile X-associated tremor/ataxia syndrome clinical core features include action tremor, gait ataxia, cognitive deficits progressing to dementia, and frequently parkinsonism. Although the pathogenic molecular mechanism of FXTAS is not completely understood, the restriction of the phenotype to the FMR1 premutation range has given rise to a model based on a RNA toxic gain-of-function. Since the identification of the first microRNAs (miRNAs) and their role in normal development, several studies have associated them with neurodegenerative diseases such as Parkinson, Alzheimer and Huntington diseases, suggesting that they play a key role in brain development, as well as in its morphogenesis. Herein, we present the characterization of miRNA expression profiles in FXTAS male patients using deep sequencing-based technologies and microarray technology. Deep sequencing analysis evidenced 83 miRNAs that were significantly deregulated whereas microarray analysis showed 31. When comparing these results, 14 miRNAs were found deregulated in FXTAS patients. MiR-424 and miR-574-3p showed significant fold change adjusted P-values in both platforms in FXTAS patients. MiR-424 has been founded substantially and specifically enriched in human cerebral cortical white matter of Alzheimer disease patients, which, together with cerebral atrophy, is a prominent imaging finding in individuals with FXTAS. The study provides the first systematic evidence of differential miRNA expression changes in FXTAS blood samples. Although further studies are necessary to better characterize the miRNA function in FXTAS disorder, our results suggest that they might contribute to its pathogenesis.
Assuntos
MicroRNAs/sangue , Idoso , Estudos de Casos e Controles , Doenças Cerebelares/diagnóstico , Doenças Cerebelares/genética , Proteína do X Frágil da Deficiência Intelectual/genética , Perfilação da Expressão Gênica , Sequenciamento de Nucleotídeos em Larga Escala , Humanos , Masculino , MicroRNAs/química , Pessoa de Meia-Idade , Análise de Sequência com Séries de Oligonucleotídeos , Análise de Sequência de DNARESUMO
BACKGROUND: Hepatoerythropoietic porphyria (HEP) is a rare form of porphyria that results from a deficiency of uroporphyrinogen decarboxylase (UROD). The disease is caused by homoallelism or heteroallelism for mutations in the UROD gene. OBJECTIVE: To study a 19-year-old woman from Equatorial Guinea, one of the few cases of HEP of African descent and to characterize a new mutation causing HEP. METHODS: Excretion of porphyrins and residual UROD activity in erythrocytes were measured and compared with those of other patients with HEP. The UROD gene of the proband was sequenced and a new mutation identified. The recombinant UROD protein was purified and assayed for enzymatic activity. The change of amino acid mapped to the UROD protein and the functional consequences were predicted. RESULTS: The patient presented a novel homozygous G170D missense mutation. Porphyrin excretion showed an atypical pattern in stool with a high pentaporphyrin III to isocoproporphyrin ratio. Erythrocyte UROD activity was 42% of normal and higher than the activity found in patients with HEP with a G281E mutation. The recombinant UROD protein showed a relative activity of 17% and 60% of wild-type to uroporphyrinogen I and III respectively. Molecular modelling showed that glycine 170 is located on the dimer interface of UROD, in a loop containing residues 167-172 that are critical for optimal enzymatic activity and that the carboxyl side chain from aspartic acid is predicted to cause negative interactions between the protein and the substrate. CONCLUSIONS: The results emphasize the complex relationship between the genetic defects and the biochemical phenotype in homozygous porphyria.
Assuntos
Mutação de Sentido Incorreto/genética , Porfiria Hepatoeritropoética/genética , Uroporfirinogênio Descarboxilase/genética , Cromatografia Líquida de Alta Pressão , Eritrócitos/enzimologia , Feminino , Técnicas de Genotipagem , Homozigoto , Humanos , Proteínas Recombinantes , Uroporfirinogênio Descarboxilase/metabolismo , Adulto JovemRESUMO
OBJECTIVES: Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neuropsychiatric degenerative disorder that occurs predominantly in male FMR1 premutation carriers. Recently, a broader FXTAS spectrum that, besides the core features of tremor and gait ataxia, also includes neuropsychiatric symptoms and neuropathy as further clinically relevant symptoms has been described among females. Herein 2 fragile X syndrome families with a mother-daughter FXTAS transmission are described in detail in order to shed more light on the female FXTAS phenotype. METHODS: Molecular characterization included CGG repeat length, X-chromosome inactivation pattern determination, as well as FMR1 mRNA and FMRP levels quantification. Neuroradiologic examination was performed by 3-T MRI. Neuropsychological assessment included global cognitive, attention, and executive prefrontal functions, verbal fluencies, verbal memory, and visuospatial perception. RESULTS: Molecular, neurologic, neuropsychiatric, psychological, cognitive, and neuroradiologic features description of 2 fragile X syndrome families with a mother-daughter FXTAS transmission in which dementia is present in both mothers. CONCLUSIONS: Although it is not yet clear to what extent FXTAS shortens lifespan, our findings show that FXTAS progresses from mild tremor and/or ataxia to disabling motor and cognitive impairment, compromising the patients' quality of life. Furthermore, our results show that FXTAS in women can also develop as a multisystem neurodegenerative disorder with central and peripheral nervous system involvement, and both motor and mental disturbances.
Assuntos
Proteína do X Frágil da Deficiência Intelectual/genética , Síndrome do Cromossomo X Frágil , Transtornos Mentais/etiologia , Transtornos dos Movimentos/etiologia , Núcleo Familiar , Expansão das Repetições de Trinucleotídeos/genética , Adulto , Idoso , Idoso de 80 Anos ou mais , Saúde da Família , Feminino , Síndrome do Cromossomo X Frágil/complicações , Síndrome do Cromossomo X Frágil/diagnóstico , Síndrome do Cromossomo X Frágil/genética , Estudo de Associação Genômica Ampla/métodos , Humanos , Imageamento por Ressonância Magnética , Masculino , Transtornos Mentais/genética , Pessoa de Meia-Idade , Relações Mãe-Filho , Transtornos dos Movimentos/genética , Testes NeuropsicológicosRESUMO
Introducción. El estudio del retraso mental es uno de los campos más complejos de la genética humana debido a la alta heterogeneidad clínica y genética que presenta. De ahí que actualmente casi un 50% de los casos permanezca sin diagnosticar. Aproximadamente, un 6-10% de los casos de retraso mental inespecífico se debe a microdeleciones o microduplicaciones en regiones subteloméricas de los cromosomas. Algunos de estos síndromes confieren un fenotipo clínicamente reconocible, como es el caso del síndrome 1p36 o la microdeleción 22q13.33, pero otros afectan a pocos pacientes y son todavía poco reconocidos. Pacientes y métodos. Se ha analizado a 300 pacientes afectados de retraso mental para reordenamientos de las regiones subteloméricas mediante una técnica sencilla, rápida y poco costosa como es la amplificación múltiple dependiente de ligación (MLPA). Resultados. Un 5,3% de los pacientes presentaron reordenamientos subteloméricos; el 75% de los casos corresponde a casos de novo, el 18,7% fueron heredados de alguno de los dos progenitores. En 14 casos las alteraciones detectadas pudieron considerarse como causantes del fenotipo que presentaban los pacientes, y en dos casos, como posibles polimorfismos. Conclusiones. Se confirma la elevada frecuencia de reordenamientos subteloméricos como causa de retraso mental y se refuerza la idea de analizar de forma rutinaria las regiones subteloméricas para llegar a un diagnóstico, establecer una correlación genotipo-fenotipo detallada y poder ofrecer un consejo genético adecuado (AU)
Introduction. The study of mental retardation is one of the most complex fields in human genetics due to its high degree of clinical and genetic heterogeneity. About 50% of cases of mental retardation remain undiagnosed. It is known that about 6-10% of cases are due to subtelomeric rearrangements. Some of these are responsible for a clinically recognized phenotype, i.e. 1p36 or 22q13.33 microdeletion syndromes, but others affect few patients and are not well characterized. Patients and methods. We have analyzed 300 consecutive mentally retarded patients for subtelomeric rearrangements by MLPA. Results. About 5.3% of patients presented subtelomeric rearrangements; from these, 75% contained de novo rearrangements and 18.7% included inherited aberrations from a healthy parent. In 14 cases, aberrations were likely related to disease and in two cases were putative polymorphisms. Conclusions. This study confirms the high frequency of subtelomeric rearrangements in mental retardation and reinforces the idea of a routine subtelomeric screening in these patients in order to get a correct diagnosis, establish genotypephenotype correlations and offer an accurate genetic counseling (AU)
Assuntos
Humanos , Rearranjo Gênico/genética , Deficiência Intelectual/genética , Anormalidades Múltiplas/genética , Telômero , Supressão Genética/genética , Duplicação GênicaAssuntos
Cromossomos Humanos X/genética , Anormalidades Congênitas/genética , Mosaicismo , Adolescente , Canal Anal/anormalidades , Mapeamento Cromossômico , Cloaca/anormalidades , Deficiências do Desenvolvimento/genética , Humanos , Hibridização in Situ Fluorescente , Cariotipagem , Masculino , Reto/anormalidades , Reto/patologia , Aberrações dos Cromossomos SexuaisRESUMO
Fragile X syndrome (FXS) is the most common inherited form of mental retardation. It is caused by a CGG repeat expansion, which results in hypermethylation and silencing of the FMR1 gene. The results from 213 FXS prenatal diagnoses performed in the study centre were reviewed. Family history of FXS or undiagnosed mental retardation (MR) were the reasons for referral and 64% of mothers were not aware of their status so prenatal and mother tests were performed at the same time. Among those women referred for family history of unknown MR, 17.6% were found to be FXS carriers. The attitudes and perceptions of the syndrome of 52 FXS carriers were also evaluated. Most of them had been diagnosed as carriers when the child was already born and the most common feeling was sadness, followed by impotence and guilt. The majority of them had received genetic counselling and they considered it useful. Regarding reproductive options, prenatal diagnosis was chosen by 40.5% of women. Prenatal diagnosis for FXS is a good reproductive option and it should be carried out whenever family history of MR is present. A high percentage of FXS carriers are detected following this approach.
Assuntos
Atitude Frente a Saúde , Síndrome do Cromossomo X Frágil/diagnóstico , Diagnóstico Pré-Natal , Feminino , Síndrome do Cromossomo X Frágil/genética , Aconselhamento Genético , Testes Genéticos , Humanos , Deficiência Intelectual/genética , Pais , Gravidez , Inquéritos e QuestionáriosRESUMO
BACKGROUND: The oligophrenin 1 gene (OPHN1) is an Rho-GTPase-activating protein involved in the regulation of the G-protein cycle required for dendritic spine morphogenesis. Mutations in this gene are implicated in X-linked mental retardation (XLMR). METHODS: We report a deletion spanning exons 21 and 22 of the OPHN1 gene identified by a tiling path X-chromosome array comparative genomic hybridization (CGH) and multiplex ligation-dependent probe amplification, confirmed by polymerase chain reaction (PCR), in a family with four males with intellectual disabilities. RESULTS: Patients harbouring mutations in this gene share the same clinical manifestations reinforcing the idea of a syndromic XLMR. The most important neurological findings are cerebellar hypoplasia and ventriculomegaly. CONCLUSIONS: We recommend screening of the OPHN1 gene in male patients with XLMR and cerebellar anomalies. This case highlights the value of high-resolution techniques as Multiplex Ligation Probe Amplification (MLPA) and CGH array for a better characterization of copy number changes and suggests that MLPA technology may be very useful for an initial screening of small deletions and duplications in XLMR patients.
Assuntos
Proteínas do Citoesqueleto/genética , Proteínas Ativadoras de GTPase/genética , Deficiência Intelectual/genética , Proteínas Nucleares/genética , Sequência de Bases/genética , Humanos , Masculino , Hibridização de Ácido Nucleico/métodos , Reação em Cadeia da Polimerase , Deleção de Sequência/genéticaRESUMO
BACKGROUND: Aproximately 5-10% of cases of mental retardation in males are due to copy number variations (CNV) on the X chromosome. Novel technologies, such as array comparative genomic hybridization (aCGH), may help to uncover cryptic rearrangements in X-linked mental retardation (XLMR) patients. We have constructed an X-chromosome tiling path array using bacterial artificial chromosomes (BACs) and validated it using samples with cytogenetically defined copy number changes. We have studied 54 patients with idiopathic mental retardation and 20 controls subjects. RESULTS: Known genomic aberrations were reliably detected on the array and eight novel submicroscopic imbalances, likely causative for the mental retardation (MR) phenotype, were detected. Putatively pathogenic rearrangements included three deletions and five duplications (ranging between 82 kb to one Mb), all but two affecting genes previously known to be responsible for XLMR. Additionally, we describe different CNV regions with significant different frequencies in XLMR and control subjects (44% vs. 20%). CONCLUSION: This tiling path array of the human X chromosome has proven successful for the detection and characterization of known rearrangements and novel CNVs in XLMR patients.
Assuntos
Cromossomos Humanos X , Variação Genética , Deficiência Intelectual Ligada ao Cromossomo X/diagnóstico , Deficiência Intelectual Ligada ao Cromossomo X/genética , Análise em Microsséries/métodos , Hibridização de Ácido Nucleico , Análise de Sequência com Séries de Oligonucleotídeos , Criança , Pré-Escolar , Aberrações Cromossômicas , Mapeamento Cromossômico , Cromossomos Artificiais Bacterianos/genética , Deleção de Genes , Dosagem de Genes , Duplicação Gênica , Humanos , Masculino , Deficiência Intelectual Ligada ao Cromossomo X/patologia , Fenótipo , Sensibilidade e EspecificidadeRESUMO
Ornithine transcarbamylase deficiency is an X-linked semidominant trait that is the most frequent inborn error of the urea cycle. Three hundred and fifty different mutations, including mostly point mutations and a small proportion of large rearrangements have been reported. Conventional molecular diagnosis is highly reliable for point mutations but can miss gross rearrangements. We describe a contiguous gene syndrome involving the RPGR, OTC and TM4SF2 genes in a male patient with severe neonatal OTC deficiency identified by the conventional molecular approach. Molecular characterization was ascertained by X chromosome CGH array and confirmed by MLPA. Complete deletion of the OTC gene led to absent OTC enzymatic activity in liver and to a severe clinical phenotype. The maternal phenotype, characterized by less severe hyperammonaemic crises associated with neurological impairment would result from a deficient but not null OTC activity due to random X chromosome inactivation in the liver. Our cases are similar toothers described presenting with OTC deficient phenotype in which OTC and contiguous genes are affected. Clinical expression would be conditioned by complete OTC deficiency in males and by X chromosome inactivation in females, leading to compensation by the normal allele in tissues such as blood or muscle but not sufficiently in liver. The application of high-resolution genetic techniques allows the characterization of causative mutations such as large deletions in order to guide genetic counselling and prenatal diagnosis.
Assuntos
Cromossomos Humanos X , Deleção de Genes , Doença da Deficiência de Ornitina Carbomoiltransferase/diagnóstico , Ornitina Carbamoiltransferase/genética , Análise Mutacional de DNA , Proteínas do Olho/genética , Feminino , Genótipo , Humanos , Recém-Nascido , Masculino , Proteínas de Membrana , Proteínas do Tecido Nervoso/genética , Doença da Deficiência de Ornitina Carbomoiltransferase/enzimologia , Doença da Deficiência de Ornitina Carbomoiltransferase/genética , Linhagem , Fenótipo , Índice de Gravidade de Doença , Síndrome , TetraspaninasRESUMO
Norrie disease (ND) is an X-linked disorder, inherited as a recessive trait that, therefore, mostly affects males. The gene responsible for ND, called NDP, maps to the short arm of chromosome X (Xp11.4-p11.3). We report here an atypical case of ND, consisting of a patient harboring a large submicroscopic deletion affecting not only the NDP gene but also the MAOA, MAOB, and EFHC2 genes. Microarray comparative genomic hybridization (CGH) analysis showed that 11 consecutive bacterial artificial chromosome (BAC) clones, mapping around the NDP gene, were deleted. These clones span a region of about 1 Mb on Xp11.3. The deletion was ascertained by fluorescent in situ hybridization (FISH) analysis with different BAC clones located within the region. Clinical features of the proband include bilateral retinal detachment, microcephaly, severe psychomotor retardation without verbal language skills acquired, and epilepsy. The identification and molecular characterization of this case reinforces the idea of a new contiguous gene syndrome that would explain the complex phenotype shared by atypical ND patients.